Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Herlev Hospital clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Denmark and Sweden registers with Herlev Hospital as lead sponsor. Synced 13 Nov 2026
18Current trials
12Recruiting now
0Drugs in these trials
2Trial registers
At a glance

Herlev Hospital is the lead sponsor of 18 current clinical trials in our Denmark and Sweden registers. 12 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Pancreatic Cancer.

ClinicalTrials.gov trials by status

  • Recruiting1267%
  • Not yet open16%
  • Active, closed211%
  • By invitation317%

Trials by phase

  • Not applicable950%
  • Observational844%
  • Phase 216%
01

Clinical trials sponsored by Herlev Hospital

18 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions
NCT07272187 · ClinicalTrials.gov ↗ · Insulinoma; Pancreas, MEN1, NETs
Observational Recruiting 2025-11 Denmark
The Role of Microbiota in Pancreatic Cancer and Precursor Lesions
NCT07250100 · ClinicalTrials.gov ↗ · Pancreatic Cancer, Microbiome
Observational Recruiting 2025-11 Denmark
Zinc Supplementation and Inflammation in Older Medical Patients
NCT07672132 · ClinicalTrials.gov ↗ · Older Medical Patients
Not applicable Recruiting 2026-06 Denmark
The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bone Mineral Density
NCT07171216 · ClinicalTrials.gov ↗ · Chronic Kidney Disease Mineral and Bone Disorder
Not applicable Recruiting 2025-11 Denmark
Exploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of Paraffinoil
NCT04265599 · ClinicalTrials.gov ↗ · Hypercalcemia, Renal Injury, Paraffinoma
Observational Recruiting 2019-04 Denmark
Platelet-Rich Plasma for Peyronie's Disease
NCT07117955 · ClinicalTrials.gov ↗ · Peyronies Disease
Not applicable Recruiting 2025-10 Denmark
Stroke School -Including Physical Exercise, Patient Education and Individual Follow-up Sessions
NCT04945174 · ClinicalTrials.gov ↗ · Minor Stroke, Non-disabling Stroke, Transient Ischemic Attack
Not applicable Recruiting 2022-06 Denmark
Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors
NCT04916132 · ClinicalTrials.gov ↗ · Chronic Kidney Diseases, Albuminuria, Diabetic Kidney Disease
Observational Recruiting 2021-08 Denmark
The CPH-MBD Cohort
NCT07193056 · ClinicalTrials.gov ↗ · Chronic Kidney Disease Mineral and Bone Disorder, Chronic Kidney Disease (CKD), Bone Markers
Observational Recruiting 2026-01 Denmark
Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer
NCT05438836 · ClinicalTrials.gov ↗ · Anal Cancer, Anal Carcinoma, Anal Squamous Cell Carcinoma
Observational Recruiting 2022-01 Denmark
Birth & Breastfeeding Support Study
NCT06844019 · ClinicalTrials.gov ↗ · Breastfeeding, Breastfeeding Initiation, Breastfeeding Duration
Observational Recruiting 2025-01 Denmark
Zinc Supplementation and Infections in Older Medical Patients
NCT07367412 · ClinicalTrials.gov ↗ · Older Adults (65 Years and Older), Medical Patients in the Emergency Department
Not applicable Recruiting 2026-02 Denmark
Molecularly Tailored Therapy in Advanced Pancreatic Cancer
NCT07802418 · ClinicalTrials.gov ↗ · Pancreatic Cancer
Phase 2 Not yet open 2026-10 Denmark
Cancer of the Prostate Treated With Focal Implantation of a RadioactivE Source
NCT06080113 · ClinicalTrials.gov ↗ · Prostate Cancer
Not applicable By invitation 2023-11 Denmark
Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance
NCT03648359 · ClinicalTrials.gov ↗ · Prostatic Neoplasms
Not applicable By invitation 2020-05 Denmark
Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance
NCT02526797 · ClinicalTrials.gov ↗ · Prostatic Neoplasms
Observational By invitation 2013-01 Denmark
High Intensity Aerobic Exercise Training and Immune Cell Mobilization in Patients With Lung Cancer (HI AIM)
NCT04263467 · ClinicalTrials.gov ↗ · Cancer, Cancer of Lung
Not applicable Active, closed 2020-08 Denmark
Accelerated Treatment of Endocarditis
NCT05144399 · Endocarditis
Not applicable Active, closed 2019-01 Sweden, Denmark

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Herlev Hospital trials

35 conditions
Pancreatic Cancer2Prostatic Neoplasms2Chronic Kidney Disease Mineral and Bone Disorder2Endocarditis1Prostate Cancer1Insulinoma; Pancreas1MEN11NETs1Radiofrequency Ablation1Microbiome1Cancer1Cancer of Lung1Older Medical Patients1Hypercalcemia1Renal Injury1Paraffinoma1Peyronies Disease1Minor Stroke1Non-disabling Stroke1Transient Ischemic Attack1Chronic Kidney Diseases1Albuminuria1Diabetic Kidney Disease1Diabetic Nephropathies1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Denmark1812
Clinical trials in Sweden10

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Pancreatic Cancer

SponsorTrials
Fudan University14
Changhai Hospital9
Peking Union Medical College Hospital7
Tianjin Medical University Cancer Institute and Hospital7
Ruijin Hospital7
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology6
IRCCS San Raffaele5
Revolution Medicines5
Alpha Tau Medical5
Akeso3

Sponsors with the most current trials registered for this condition.

05

Questions about Herlev Hospital trials

How many clinical trials does Herlev Hospital sponsor?

Herlev Hospital is the lead sponsor of 18 current trials on ClinicalTrials.gov in our Denmark and Sweden registers, as of the registry sync on 13 November 2026. Completed and withdrawn studies are not counted.

Are Herlev Hospital trials recruiting?

Yes. 12 of its 18 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 13 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.